Racial Variation in the Cost-effectiveness of Chemotherapy for Prostate Cancer
May 18th 2011The likelihood of chemotherapy being cost-effective for patients with metastatic prostate cancer differs across racial subgroups. This uncertainty presents challenges for managed-care decision makers.
Impact of Clinical Oral Chemotherapy Program on Wastage and Hospitalizations
May 16th 2011An oral chemotherapy cycle management program offers clinical support, reduces medication wastage, and provides management of adverse effects to realize cost savings for payers and patients.
Genomic Testing and Therapies for Breast Cancer in Clinical Practice
May 15th 2011Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.
Journey Forward: The New Face of Cancer Survivorship Care
May 13th 2011WellPoint, UCLA's Jonsson Comprehensive Cancer Center, the National Coalition for Cancer Survivorship (NCCS) and Genentech collaborated to develop Journey Forward, a first-of-its-kind program for coordinating post-treatment care.